Co-Expression of GRK2 Reveals a Novel Conformational State of the µ-Opioid Receptor

Increased Agonist Affinity at the  -Opioid Receptor Induced by Prolonged Agonist Exposure

(2013) W. T. Birdsong et al.   JOURNAL OF NEUROSCIENCE

Distinct CCK-2 Receptor Conformations Associated with β-Arrestin-2 Recruitment or Phospholipase-C Activation Revealed by a Biased Antagonist

(2013) Rémi Magnan et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Signalling bias in new drug discovery: detection, quantification and therapeutic impact

(2013) Terry Kenakin et al.   NATURE REVIEWS DRUG DISCOVERY

Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells

(2012) Christian Doll et al.   BRITISH JOURNAL OF PHARMACOLOGY

Identification of phosphorylation sites in the COOH-terminal tail of the μ-opioid receptor

(2012) Ying-Ju Chen et al.   JOURNAL OF NEUROCHEMISTRY

Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor

(2012) S. Mary et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

GRK2: multiple roles beyond G protein-coupled receptor desensitization

(2012) Tama Evron et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Beta-Arrestin2 as a Competitor for GRK2 Interaction with the GLP-1 Receptor upon Receptor Activation

(2011) Rasmus Jorgensen et al.   PHARMACOLOGY

Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery

(2010) T. Kenakin et al.   PHARMACOLOGICAL REVIEWS

Gα-Subunits Differentially Alter the Conformation and Agonist Affinity of κ-Opioid Receptors†

(2008) Feng Yan et al.   BIOCHEMISTRY